Government to enable medicines to be approved in less than 30 days if the product has approval from two recognised overseas jurisdictions. Our cause supports reduced wait times for patients to access treatments that will be life-changing. Sufficient funding will be paramount. #accesstotreatmentisaccesstolife #lungcancermatters https://www.beehive.govt.nz/release/rule-two-faster-access-medicines?trk=feed_main-feed-card_feed-article-content&fbclid=IwY2xjawJceDBleHRuA2FlbQIxMQABHVMsp0J_j1FpMRBs_FOqtqXozGcde_SBfTvcOt2Yw-rcvo2y3lYYY817zw_aem_A614R4207mJ75IdL8UtEOQ
2025
Lung Cancer Patient, Ben Wilson shares his story
Lung Cancer Patient Advocate Ben Wilson of Tuakau (South of Auckland) is a funeral director and celebrant. Ben is 39 years of age. He lives with his fiancée Emma. Together they share 4 children; Logan, Grace, Isaac and Peyton. Ben is the Deputy Chief Fire Officer for the Tuakau Volunteer Fire Brigade. Grateful thanks to Ben […]
Pharmac Consumer Engagement Workshop Report welcomed
Lung Foundation NZ was one of the patient groups that took part in the review of Pharmac in the form of interactive workshops for sector leaders held in Wellington. This included delivering presentations, peer review and providing submissions to inform the final report. #accesstotreatmentisaccesstolife #lungcancermatters https://www.beehive.govt.nz/release/pharmac-consumer-engagement-workshop-report-welcomed?fbclid=IwY2xjawJcEfhleHRuA2FlbQIxMQABHWKIncXmhD73JhE_ONrSrD4U3WL2xuYO9wZ6AVum06gH0lTfeh2FupRRAw_aem_3dPCxqZZz31nEZ7sl8V8KA
Stigma Kills
The only thing more deadly than lung cancer is the myth that it is a smokers disease. FACT: Anyone cancer get lung cancer – if you have lungs you can get lung cancer. #educatetoendstigma #lungcancermatters #accesstotreatmentisaccesstolife About Lung Cancer in New Zealand: Lung Cancer is NZ’s Biggest Cancer Killer. 5 Kiwis die every day […]
Funding Osimertinib for EGFR, Stage 4 Non-Small Cell Lung Cancer
The funding announcement for osimertinib is a breath of equity because it meets the greatest treatment need right now. Osimertinib is the gold standard for EGFR, stage 4, Non-Small Cell Lung Cancer (NSCLC) and it will be life changing for patients and their families. We want to acknowledge the leaders and clinical advisors at Pharmac […]
